| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Collaboration and license revenue | $21.0M+55.5% | $13.5M+33.5% | $10.1M+834.7% | $1.1M |
| Research and development | $88.2M+47.4% | $59.8M+33.1% | $45.0M+118.5% | $20.6M |
| General and administrative | $26.4M+29.5% | $20.4M+47.2% | $13.8M+105.1% | $6.7M |
| Total operating expenses | $114.5M+42.8% | $80.2M+36.4% | $58.8M+115.2% | $27.3M |
| Loss from operations | -$93.5M-40.3% | -$66.6M-37.0% | -$48.6M-85.4% | -$26.2M |
| Interest and other income, net | $8.0M+402.8% | $1.6M+9843.8% | $16K | — |
| Interest expense | -$3.8M-219.6% | -$1.2M | — | — |
| Total other income | $4.2M+921.7% | $415K+2493.8% | $16K | — |
| Net loss | -$89.2M-34.7% | -$66.2M-36.2% | -$48.6M-86.1% | -$26.1M |
| Net loss per share, basic | -$1360.00+50.5% | -$2750.00+34.1% | -$4170.00 | — |
| Net loss per share, diluted | -$1360.00+50.5% | -$2750.00+34.1% | -$4170.00 | — |
| Weighted average common shares outstanding- basic | 65.60B+172.8% | 24.05B+106.2% | 11.66B | — |
| Weighted average common shares outstanding-diluted | 65.60B+172.8% | 24.05B+106.2% | 11.66B | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.